These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12722406)

  • 21. Preliminary experience with a modified Tenckhoff catheter for intraperitoneal chemotherapy.
    Nguyen HN; Averette HE; Wyble L; Sevin BU; Donato D; Penalver M
    J Surg Oncol; 1993 Apr; 52(4):237-40. PubMed ID: 8468986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of complications associated with catheter intraperitoneal chemotherapy of ovarian carcinoma].
    Wei LH; Qian HN; Li WF
    Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):732-4, 762-3. PubMed ID: 7712902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Problems associated with the administration of intraperitoneal therapy using the Port-A-Cath system.
    Almadrones L; Yerys C
    Oncol Nurs Forum; 1990; 17(1):75-80. PubMed ID: 2300507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified technique for insertion of intraperitoneal port for chemotherapy.
    Liou WS; Teng NN; Chan JK
    J Surg Oncol; 2005 Jun; 90(4):247-8. PubMed ID: 15906367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.
    Lesnock JL; Richard SD; Zorn KK; Krivak TC; Beriwal S; Sukumvanich P; McBee WC; Kelley JL; Edwards RP
    Gynecol Oncol; 2010 Mar; 116(3):345-50. PubMed ID: 19959211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder erosion by an intraperitoneal chemotherapy catheter resulting in catheter protrusion through the external urethral meatus.
    Bryant CS; Shah JP; Triest JA; Schimp VL; Morris RT
    Gynecol Oncol; 2008 Dec; 111(3):552-4. PubMed ID: 18289650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ports and complications for intraperitoneal chemotherapy delivery.
    Helm CW
    BJOG; 2012 Jan; 119(2):150-9. PubMed ID: 22017885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term access to the peritoneal cavity in ovarian cancer patients.
    Rubin SC; Hoskins WJ; Markman M; Hakes T; Lewis JL
    Gynecol Oncol; 1989 Apr; 33(1):46-8. PubMed ID: 2703166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroscopically guided peritoneal catheter placement for intraperitoneal chemotherapy.
    Rundback JH; Gray RJ; Buck DR; Dolmatch BL; Haffner GH; Horton KM; Jelinek JS; Maxwell DD; Steves MA; Sugarbaker PH
    J Vasc Interv Radiol; 1994; 5(1):161-5. PubMed ID: 8136597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications associated with 9-10Fr venous access port use in adjuvant intraperitoneal chemotherapy after a cytoreductive surgery in ovarian cancer patients.
    Milczek T; Klasa-Mazurkiewicz D; Wydra D
    Adv Med Sci; 2015 Sep; 60(2):216-9. PubMed ID: 25863871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of intraperitoneal chemotherapy into the pleural cavity.
    Vaccarello L; Berghella V; Rubin SC; Hoskins WJ
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):714-7. PubMed ID: 9205461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institution's experience.
    Ivy JJ; Geller M; Pierson SM; Jonson AL; Argenta PA
    Gynecol Oncol; 2009 Sep; 114(3):420-3. PubMed ID: 19560189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
    Kehoe SM; Williams NL; Yakubu R; Levine DA; Chi DS; Sabbatini PJ; Aghajanian CA; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2009 May; 113(2):228-32. PubMed ID: 19254808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral Chemotherapy.
    Nicoletto MO; Casarin A; Baldoni A; Rulli E; Tasca G; Baretta Z; Artioli G; Lombardi G; Cappetta A; Floriani I; Randon G; Valpione S; Litta P; Conte P; Mocellin S; Aliberti C
    Anticancer Res; 2016 Dec; 36(12):6541-6546. PubMed ID: 27919980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic Tenckhoff catheter insertion: a retrospective study over 6 years.
    Bunker D; Ilie V; Fisher D
    ANZ J Surg; 2014; 84(1-2):73-7. PubMed ID: 22985018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.
    Topuz E; Salihoglu Y; Aydiner A; Saip P; Tas F; Sozen T; Berkman S; Bengisu E
    J Surg Oncol; 2000 Jul; 74(3):223-6. PubMed ID: 10951423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of intraperitoneal drug distribution during intraperitoneal chemotherapy using saline-injected MR imaging through an implanted catheter-port system].
    Obuchi M; Shimizu A; Fujiwara T; Sugimoto H; Honda M; Kubota H; Yamamoto W; Kinebuchi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1891-5. PubMed ID: 11729482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
    Myers CE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter complications associated with intraperitoneal chemotherapy.
    Runowicz CD; Dottino PR; Shafir MK; Mark MA; Cohen CJ
    Gynecol Oncol; 1986 May; 24(1):41-50. PubMed ID: 3699576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.